CDX2 mutations and their link to juvenile polyposis and Peutz–Jeghers syndrome
Author Information
Author(s): Woodford-Richens K L, Halford S, Rowan A, Bevan S, Aaltonen L A, Wasan H, Bicknell D, Bodmer W F, Houlston R S, Tomlinson I P M
Primary Institution: Molecular and Population Genetics Laboratory, Imperial Cancer Research Fund
Hypothesis
CDX2 mutations may be involved in juvenile polyposis and Peutz–Jeghers syndrome, as well as sporadic colorectal cancers.
Conclusion
The study found no pathogenic CDX2 mutations in juvenile polyposis, Peutz–Jeghers syndrome, or sporadic colorectal cancers.
Supporting Evidence
- No pathogenic CDX2 mutations were found in juvenile polyposis cases.
- No pathogenic CDX2 mutations were found in Peutz–Jeghers syndrome cases.
- No pathogenic CDX2 mutations were found in sporadic colorectal cancers.
Takeaway
The researchers looked for a specific gene mutation in families with certain types of polyps and found that it wasn't the cause of their conditions.
Methodology
The study screened 37 juvenile polyposis families, 10 Peutz-Jeghers cases, and 49 sporadic colorectal cancers for CDX2 mutations.
Limitations
The study only screened for CDX2 mutations and did not explore other potential genetic factors.
Participant Demographics
Families with juvenile polyposis and Peutz–Jeghers syndrome, and individuals with sporadic colorectal cancers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website